23 January 2025
Judges Scientific plc
("Judges Scientific" or the "Company")
Grant of Options
Judges Scientific announces that it has issued options over 76,500 new ordinary shares of 5 pence each in the Company ("Ordinary Shares") at an exercise price per share of £76.90, being the closing mid-price on 22 January 2025.
76,500 options have been awarded in total by the Remuneration Committee to certain of the Directors, as shown in the table below, to retain and incentivise them. Vesting of the options after three years is subject to the achievement of 5% compound growth in adjusted earnings per share over the vesting period, and to continued employment.
Director |
Number of options |
Option Scheme |
Vesting date |
Expiry date |
Tim Prestidge |
60,000 |
Unapproved |
23/01/2028 |
22/01/2035 |
David Cicurel |
5,500 |
Unapproved |
23/01/2028 |
22/01/2035 |
Brad Ormsby |
5,500 |
Unapproved |
23/01/2028 |
22/01/2035 |
Mark Lavelle |
5,500 |
Unapproved |
23/01/2028 |
22/01/2035 |
The Remuneration Committee seeks through its award of share options to motivate, retain and incentivise executives of the calibre that will grow shareholder value successfully. The share option awards align the interests of executives and shareholders. Tim Prestidge, Group Business Development Director, has been issued additional options as his original share options from the time of his appointment, which were granted on 31 March 2023, were issued with a 10% compound growth rate, prior to the enactment of the increase in UK corporation tax from 19% to 25%. In this context, the Remuneration Committee consider such compound performance target to be overly ambitious for the vesting period.
Further it is noted that the Company erroneously omitted disclosing the issue of share options to Ian Wilcock, Group Commercial Director, when he joined the Company. The award of options, which was made on 19 September 2024, is summarised below.
Director |
Number of options |
Exercise price |
Option Scheme |
Vesting date |
Expiry date |
Ian Wilcock |
305 |
£98.30 |
Approved |
19/09/2027 |
19/09/2034 |
Ian Wilcock |
29,695 |
£98.30 |
Unapproved |
19/09/2027 |
19/09/2034 |
For further information please contact:
|
|
|
|
Judges Scientific plc David Cicurel, CEO Brad Ormsby, CFO Tel: +44 (0) 20 3829 6970
|
Shore Capital (Nominated Adviser & Joint Broker) Stephane Auton Harry Davies-Ball Tel: +44 (0) 20 7408 4090
|
|
|
Liberum (Joint Broker) Edward Mansfield Nikhil Varghese Joshua Borlant Tel : +44 (0) 20 3100 2222
|
Investec Bank plc (Joint Broker) Virginia Bull Carlton Nelson Tel: +44 (0) 207 597 4000 |
|
|
Alma (Financial Public Relations) Sam Modlin Rebecca Sanders-Hewett Joe Pederzolli Sarah Peters Tel: +44 (0) 20 3405 0205 judges@almastrategic.com |
|
|
|
|
|
|
|
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group consists of 25 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
Judges Scientific plc
Director/PDMR Shareholding
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
David Cicurel |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Chief Executive Officer |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Judges Scientific plc |
||||
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
b)
|
Nature of the transaction
|
Grant of Options |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
e)
|
Date of the transaction
|
23/01/2025 |
||||
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
Judges Scientific plc
Director/PDMR Shareholding
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Bradley Ormsby |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Chief Financial Officer |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Judges Scientific plc |
||||
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
b)
|
Nature of the transaction
|
Grant of Options |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
e)
|
Date of the transaction
|
23/01/2025 |
||||
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
Judges Scientific plc
Director/PDMR Shareholding
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Mark Lavelle |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Chief Operating Officer |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Judges Scientific plc |
||||
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
b)
|
Nature of the transaction
|
Grant of Options |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
e)
|
Date of the transaction
|
23/01/2025 |
||||
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
Judges Scientific plc
Director/PDMR Shareholding
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Tim Prestidge |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Group Business Development Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Judges Scientific plc |
||||
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
b)
|
Nature of the transaction
|
Grant of Options |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
e)
|
Date of the transaction
|
23/01/2025 |
||||
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |
Judges Scientific plc
Director/PDMR Shareholding
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
a)
|
Name
|
Ian Wilcock |
||||
2
|
Reason for the notification
|
|||||
a)
|
Position/status
|
Group Commercial Director |
||||
b)
|
Initial notification /Amendment
|
Initial notification |
||||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
a)
|
Name
|
Judges Scientific plc |
||||
b)
|
LEI
|
2138004EXWWPTW1JOL31 |
||||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Ordinary shares in Judges Scientific plc
GB0032398678
|
||||
b)
|
Nature of the transaction
|
Grant of Options |
||||
c)
|
Price(s) and volume(s)
|
|
||||
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A (single transaction) |
||||
e)
|
Date of the transaction
|
19/09/2024 |
||||
f)
|
Place of the transaction
|
London Stock Exchange, AIM Market (XLON) |